109 related articles for article (PubMed ID: 8647661)
1. Circulating immune complexes in various forms of Behçet's disease.
Abdallah MA; Ragab N; Khalil R; Kamel N
Int J Dermatol; 1995 Dec; 34(12):841-5. PubMed ID: 8647661
[TBL] [Abstract][Full Text] [Related]
2. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G
Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603
[TBL] [Abstract][Full Text] [Related]
3. Fibronectin and circulating immune complexes in Behet's disease.
Ozoran K; Düzgün N; Tutkak H; Gürler A; Tokgöz G
Rheumatol Int; 1996; 15(6):221-4. PubMed ID: 8778949
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexome analysis identified anti-tubulin-α-1c as an inflammation associated autoantibody with promising diagnostic value for Behcet's Disease.
Cheng Y; Zhao X; Chen Y; Li Y; Jia R; Zhu L; Huang C; Sun X; Deng H; Li Z
PLoS One; 2018; 13(6):e0199047. PubMed ID: 29902281
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of late-onset Behçet's disease: report of nine cases.
Saricaoglu H; Karadogan SK; Bayazit N; Yucel A; Dilek K; Tunali S
Int J Dermatol; 2006 Nov; 45(11):1284-7. PubMed ID: 17076707
[TBL] [Abstract][Full Text] [Related]
6. Pathergy reaction in Behçet's disease: lack of correlation with mucocutaneous manifestations and systemic disease expression.
Krause I; Molad Y; Mitrani M; Weinberger A
Clin Exp Rheumatol; 2000; 18(1):71-4. PubMed ID: 10728447
[TBL] [Abstract][Full Text] [Related]
7. Behçet's disease in southern Chinese patients.
Mok CC; Cheung TC; Ho CT; Lee KW; Lau CS; Wong RW
J Rheumatol; 2002 Aug; 29(8):1689-93. PubMed ID: 12180731
[TBL] [Abstract][Full Text] [Related]
8. Predictive Factors of Severe Behçet's disease: A Longitudinal, Prospective Cohort Followed Between 1981-2020.
Serpa Pinto L; Xavier Pires S; Silva B; Farinha F; Vasconcelos C; Araújo Correia J
Reumatol Clin (Engl Ed); 2022; 18(7):410-415. PubMed ID: 35940675
[TBL] [Abstract][Full Text] [Related]
9. Anti-Saccharomyces cerevisiae antibodies in Behçet's disease--a familial study.
Monselise A; Weinberger A; Monselise Y; Fraser A; Sulkes J; Krause I
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S87-90. PubMed ID: 17067434
[TBL] [Abstract][Full Text] [Related]
10. Circulating soluble immume complexes in recurrent oral ulceration and Behçet's syndrome.
Levinsky RJ; Lehner T
Clin Exp Immunol; 1978 May; 32(2):193-8. PubMed ID: 668196
[TBL] [Abstract][Full Text] [Related]
11. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
[TBL] [Abstract][Full Text] [Related]
12. Behçet's syndrome: immune regulation, circulating immune complexes, neutrophil migration, and colchicine therapy.
Jorizzo JL; Hudson RD; Schmalstieg FC; Daniels JC; Apisarnthanarax P; Henry JC; Gonzalez EB; Ichikawa Y; Cavallo T
J Am Acad Dermatol; 1984 Feb; 10(2 Pt 1):205-14. PubMed ID: 6371066
[TBL] [Abstract][Full Text] [Related]
13. Histopathological and clinical evaluation of papulopustular lesions in Behçet's disease.
Kutlubay Z; Mat CM; Aydin Ö; Demirkesen C; Calay Ö; Engın B; Tüzün Y; Yazici H
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S101-6. PubMed ID: 26344806
[TBL] [Abstract][Full Text] [Related]
14. Erythema nodosum-like lesions in Behçet's disease: a clinicopathological study of 26 cases.
Misago N; Tada Y; Koarada S; Narisawa Y
Acta Derm Venereol; 2012 Nov; 92(6):681-6. PubMed ID: 22504656
[TBL] [Abstract][Full Text] [Related]
15. The IL-8 Gene Polymorphisms in Behçet's Disease Observed in Denizli Province of Turkey.
Atalay A; Arıkan S; Ozturk O; Öncü M; Tasli ML; Duygulu S; Atalay EO
Immunol Invest; 2016 May; 45(4):298-311. PubMed ID: 27101127
[TBL] [Abstract][Full Text] [Related]
16. Immune complexes in Behçet's syndrome and recurrent oral ulceration.
Williams BD; Lehner T
Br Med J; 1977 May; 1(6073):1387-9. PubMed ID: 324574
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of Behçet's disease: A retrospective chart review of 26 patients.
Davari P; Rogers RS; Chan B; Nagler TH; Fazel N
J Dermatolog Treat; 2016; 27(1):70-4. PubMed ID: 26108444
[TBL] [Abstract][Full Text] [Related]
18. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of GRO-α are elevated in association with disease activity in patients with Behçet's disease.
Kato Y; Yamamoto T
Int J Dermatol; 2012 Mar; 51(3):286-9. PubMed ID: 22348563
[TBL] [Abstract][Full Text] [Related]
20. Behçet's disease in India: a dermatological perspective.
Singal A; Chhabra N; Pandhi D; Rohatgi J
Indian J Dermatol Venereol Leprol; 2013; 79(2):199-204. PubMed ID: 23442458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
